Literature DB >> 9862140

Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum.

S el-Mekkawy1, M R Meselhy, N Nakamura, Y Tezuka, M Hattori, N Kakiuchi, K Shimotohno, T Kawahata, T Otake.   

Abstract

A new highly oxygenated triterpene named ganoderic acid alpha has been isolated from a methanol extract of the fruiting bodies of Ganoderma lucidum together with twelve known compounds. The structures of the isolated compounds were determined by spectroscopic means including 2D-NMR. Ganoderiol F and ganodermanontriol were found to be active as anti-HIV-1 agents with an inhibitory concentration of 7.8 micrograms ml-1 for both, and ganoderic acid B, ganoderiol B, ganoderic acid C1, 3 beta-5 alpha-dihydroxy-6 beta-methoxyergosta-7,22-diene, ganoderic acid alpha, ganoderic acid H and ganoderiol A were moderately active inhibitors against HIV-1 PR with a 50% inhibitory concentration of 0.17-0.23 mM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862140     DOI: 10.1016/s0031-9422(98)00254-4

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  37 in total

1.  Inhibitory effects of triterpenoids and sterols on human immunodeficiency virus-1 reverse transcriptase.

Authors:  T Akihisa; J Ogihara; J Kato; K Yasukawa; M Ukiya; S Yamanouchi; K Oishi
Journal:  Lipids       Date:  2001-05       Impact factor: 1.880

2.  Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients.

Authors:  Changda Liu; Nan Yang; Ying Song; Lixin Wang; Jiachen Zi; Shuwei Zhang; David Dunkin; Paula Busse; David Weir; Jody Tversky; Rachel L Miller; Joseph Goldfarb; Jixun Zhan; Xiu-Min Li
Journal:  Int Immunopharmacol       Date:  2015-05-21       Impact factor: 4.932

Review 3.  Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling.

Authors:  Balraj Singh Gill; Prateek Sharma; Raj Kumar; Sanjeev Kumar
Journal:  Tumour Biol       Date:  2015-12-30

4.  Antiviral activity of Basidiomycete mycelia against influenza type A (serotype H1N1) and herpes simplex virus type 2 in cell culture.

Authors:  Tetiana Krupodorova; Svetlana Rybalko; Victor Barshteyn
Journal:  Virol Sin       Date:  2014-10-24       Impact factor: 4.327

5.  Trichoderone, a novel cytotoxic cyclopentenone and cholesta-7, 22-diene-3 beta, 5 alpha, 6 beta-triol, with new activities from the marine-derived fungus Trichoderma sp.

Authors:  Jianlan You; Huanqin Dai; Zhihui Chen; Guangjie Liu; Zhengxiang He; Fuhang Song; Xiang Yang; Haian Fu; Lixin Zhang; Xiaoping Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2010-03       Impact factor: 3.346

6.  Apoptotic and Immune Restoration Effects of Ganoderic Acids Define a New Prospective for Complementary Treatment of Cancer.

Authors:  Faisal F Y Radwan; J Manuel Perez; Azizul Haque
Journal:  J Clin Cell Immunol       Date:  2011-12-11

7.  Metabolism and pharmacokinetics in rats of ganoderiol F, a highly cytotoxic and antitumor triterpene from Ganoderma lucidum.

Authors:  Qun Zhang; Feng Zuo; Norio Nakamura; Chao-Mei Ma; Masao Hattori
Journal:  J Nat Med       Date:  2009-05-01       Impact factor: 2.343

Review 8.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

Review 9.  Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.

Authors:  Ulrike Grienke; Teresa Kaserer; Florian Pfluger; Christina E Mair; Thierry Langer; Daniela Schuster; Judith M Rollinger
Journal:  Phytochemistry       Date:  2014-11-06       Impact factor: 4.072

10.  Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance.

Authors:  Qing-Ping Wu; Yi-Zhen Xie; Zhaoqun Deng; Xiang-Min Li; Weining Yang; Chun-Wei Jiao; Ling Fang; Sen-Zhu Li; Hong-Hui Pan; Albert J Yee; Daniel Y Lee; Chong Li; Zhi Zhang; Jun Guo; Burton B Yang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.